According to MarketsandMarkets™, the global Cell-Based Assays Market is projected to reach USD 25.77 billion by 2030, up from USD 18.13 billion in 2025, growing at a CAGR of 7.3% during the forecast period. This growth is fueled by the increasing demand for advanced drug discovery tools, rising R&D investments, and significant progress in cancer research and personalized medicine.
The integration of artificial intelligence (AI) into cell-based research workflows is emerging as a transformative trend, enhancing assay efficiency, accuracy, and scalability. However, the market continues to face challenges such as the high cost of assay products and technical complexities associated with assay development and reproducibility.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269
Browse
- 564 Market Data Tables
- 60 Figures
- 448 Pages and in-depth TOC on “ Cell Based Assays Market – Global Forecast to 2030”.
Key Market Drivers
The surge in pharmaceutical and biopharmaceutical R&D activities, particularly in oncology and precision medicine, is a major factor driving the adoption of cell-based assays. These assays play a critical role in toxicity testing, pharmacokinetics/pharmacodynamics (PK/PD) studies, and high-throughput screening (HTS), making them indispensable in modern drug development pipelines. Additionally, increasing investments in cellular therapies and biologics are further accelerating market expansion.
Segment Insights
By offering, the consumables segment dominated the market in 2024. This segment includes reagents, assay kits, cell lines, microplates, probes, and labels, which are essential for ensuring reliable and reproducible experimental outcomes. The growing demand for high-quality reagents and the expansion of cell-based research applications are key contributors to this segment’s leadership.
By end user, pharmaceutical & biopharmaceutical companies accounted for the largest market share in 2024. This dominance is attributed to the rising need for innovative therapeutics, increased prevalence of chronic diseases such as cancer, and a strong pipeline of drug development programs. The growing emphasis on personalized medicine and targeted therapies is further strengthening demand within this segment.
Regional Outlook
The Asia Pacific region is expected to register the highest CAGR during the forecast period. Rapid growth in this region is driven by expanding healthcare infrastructure, increased government funding for research, and a growing focus on developing cell-based and regenerative therapies. The adoption of advanced technologies and the rise of contract research organizations (CROs) are also contributing to regional market expansion.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=119917269
Competitive Landscape
The global cell-based assays market is highly competitive, with leading players focusing on innovation, strategic collaborations, and portfolio expansion. Key companies operating in this space include BD, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies, Lonza, Charles River Laboratories, Bio-Rad Laboratories, Revvity, Sartorius AG, Corning Incorporated, Promega Corporation, and Eurofins Scientific, among others.
As the demand for efficient, scalable, and predictive drug discovery solutions continues to grow, the cell-based assays market is set to witness sustained expansion, supported by technological advancements and increasing global research investments.
Related Reports:
Cell Expansion Market – Global Forecast to 2029
Immunoassay Market– Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html